MSD Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy

Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease

C-SURFER Trial is First to Investigate an All-Oral Ribavirin-Free Hepatitis C Treatment Regimen in Treatment-Naïve and Treatment-Experienced Patients with Advanced Chronic Kidney Disease Infected with Hepatitis C Virus Genotype 1

businesswire.com/news/home/...

oldestnewest

You may also like...